Rapuano, Christopher J.
Beckman, Kenneth A.
Rajpal, Rajesh
Article History
Received: 5 November 2025
Accepted: 2 February 2026
First Online: 3 March 2026
Declarations
:
: Christopher J. Rapuano has nothing to disclose. Kenneth A. Beckman: Glaukos (consulting and contracted research). Oculus (consulting). Rajesh Rajpal: Glaukos—Consultant/Advisor. Other disclosures not relevant to manuscript: Horizon Surgical—employee/shareholder, Ufonia – investor. EyeDura—investor. Lightfield Medical—shareholder. Heru–shareholder. SANNT—investor/consultant. Abbvie—consultant. J&J—former employee/shareholder.
: This narrative review was based on previously published studies, and no new studies involving human or animal participants were performed.